Nicotinamide mononucleotide enhances anti-tumor effect by resetting macrophages toward the inflammatory M1-like phenotype.

Xu H, Wan MCT, Wong CCC, Qin S, Wen Y, Wang J, Chen Z

Open source

DOI
10.1016/j.omton.2026.201221
Published
2026 Jun 18
Container
Molecular therapy. Oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omton.2026.201221,
  title = {Nicotinamide mononucleotide enhances anti-tumor effect by resetting macrophages toward the inflammatory M1-like phenotype.},
  author = {Xu H and Wan MCT and Wong CCC and Qin S and Wen Y and Wang J and Chen Z},
  year = {2026},
  journal = {Molecular therapy. Oncology},
  doi = {10.1016/j.omton.2026.201221},
  url = {https://doi.org/10.1016/j.omton.2026.201221}
}

RIS

TY  - JOUR
TI  - Nicotinamide mononucleotide enhances anti-tumor effect by resetting macrophages toward the inflammatory M1-like phenotype.
AU  - Xu H
AU  - Wan MCT
AU  - Wong CCC
AU  - Qin S
AU  - Wen Y
AU  - Wang J
AU  - Chen Z
PY  - 2026
JO  - Molecular therapy. Oncology
DO  - 10.1016/j.omton.2026.201221
UR  - https://doi.org/10.1016/j.omton.2026.201221
ER  - 

APA

H, X., MCT, W., CCC, W., S, Q., Y, W., J, W., & Z, C. (2026). Nicotinamide mononucleotide enhances anti-tumor effect by resetting macrophages toward the inflammatory M1-like phenotype.. Molecular therapy. Oncology. https://doi.org/10.1016/j.omton.2026.201221

Source records